Compile Data Set for Download or QSAR
Report error Found 752 of affinity data for UniProtKB/TrEMBL: Q9UKP6
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112103(Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val | CHEMBL216349)
Affinity DataEC50:  3.60nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112104(Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Ala-Cys-Val | CHEM...)
Affinity DataEC50:  193nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112102(Glu-Thr-Pro-Asp-Cys-Phe-Lys-Tyr-Cys-Val | CHEMBL38...)
Affinity DataEC50: >1.00E+4nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112105(Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Ala | CHEM...)
Affinity DataEC50:  3.20nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112106(Glu-Thr-Pro-Asp-Cys-D-Phe-Trp-Lys-Tyr-Cys-Val | CH...)
Affinity DataEC50:  1.00E+3nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112107(Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys | CHEMBL38...)
Affinity DataEC50:  1.80nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112108(Glu-Thr-Pro-Asp-Ala-Phe-Trp-Lys-Tyr-Cys-Val | CHEM...)
Affinity DataEC50:  233nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112110(Glu-Thr-Ala-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val | CHEM...)
Affinity DataEC50:  1.90nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112109(Ala-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val | CHEM...)
Affinity DataEC50:  1.80nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112112(Glu-Thr-Pro-Asp-Cys-Phe-Trp-Ala-Tyr-Cys-Val | CHEM...)
Affinity DataEC50:  1.48E+4nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112111(Cys-Phe-Trp-Lys-Tyr-Cys | CHEMBL298803)
Affinity DataEC50:  2.30nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112113(Glu-Thr-Pro-Ala-Cys-Phe-Trp-Lys-Tyr-Cys-Val | CHEM...)
Affinity DataEC50:  2.70nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112114(Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val | CHEMBL42...)
Affinity DataEC50:  2.40nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112115(Glu-Thr-Pro-Asp-Cys-Trp-Lys-Tyr-Cys-Val | CHEMBL41...)
Affinity DataEC50:  53nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112118(Glu-Thr-Pro-Asp-Cys-Phe-D-Trp-Lys-Tyr-Cys-Val | CH...)
Affinity DataEC50:  3.80nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112116(Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val | CHEMBL414256)
Affinity DataEC50:  3nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112117(Glu-Thr-Pro-Asp-Cys-Phe-Ala-Lys-Tyr-Cys-Val | CHEM...)
Affinity DataEC50:  1.30E+3nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112120(Cys-Phe-Trp-Lys-Tyr-Cys-Val | CHEMBL53181)
Affinity DataEC50:  1.80nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112119(Glu-Thr-Pro-Asp-Cys-Phe-Trp-D-Lys-Tyr-Cys-Val | CH...)
Affinity DataEC50: >1.00E+4nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112121(Glu-Ala-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val | CHEM...)
Affinity DataEC50:  3.30nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112122(Glu-Thr-Pro-Asp-Cys-Ala-Trp-Lys-Tyr-Cys-Val | CHEM...)
Affinity DataEC50:  5.70nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50112123(Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val | CHEM...)
Affinity DataEC50:  2.5nMAssay Description:Mobilization of intracellular calcium in CHO cells transiently transfected with human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50164423({2-[2-(4-Chloro-phenyl)-4-phenyl-2,3-dihydro-benzo...)
Affinity DataEC50:  6.30E+3nMAssay Description:Agonist activity for human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50164424(3-(4-chlorophenyl)-3-(2-(dimethylamino)ethyl)isoch...)
Affinity DataEC50:  300nMAssay Description:Agonist activity for human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50164425({2-[5-(4-Chloro-phenyl)-1-methyl-3-phenyl-4,5-dihy...)
Affinity DataEC50:  4.00E+3nMAssay Description:Agonist activity for human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50164426(4-(4-Chloro-phenyl)-5-(2-diethylamino-ethyl)-3-met...)
Affinity DataEC50:  5.00E+3nMAssay Description:Agonist activity for human Urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50164424(3-(4-chlorophenyl)-3-(2-(dimethylamino)ethyl)isoch...)
Affinity DataEC50:  250nMAssay Description:Agonist activity at human urotensin 2 expressed in CHO cells by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2010
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50378580(CHEMBL437430)
Affinity DataEC50:  1.09nMAssay Description:Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2012
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50304252((6S,9S,12S,15S,20aS)-9-((1H-indol-3-yl)methyl)-12-...)
Affinity DataEC50:  6.94nMAssay Description:Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2012
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50304253((6S,9S,12S,15S,20aS)-9-((1H-indol-3-yl)methyl)-12-...)
Affinity DataEC50:  8.51nMAssay Description:Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2012
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50304254((6S,9S,12S,15S,20aS)-9-((1H-indol-3-yl)methyl)-12-...)
Affinity DataEC50:  12.6nMAssay Description:Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2012
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50304255((6S,9S,12S,15S,20aS)-9-((1H-indol-3-yl)methyl)-12-...)
Affinity DataEC50:  13.2nMAssay Description:Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2012
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50304256((6S,9S,12S,15S,20aS)-9-((1H-indol-3-yl)methyl)-12-...)
Affinity DataEC50:  10.1nMAssay Description:Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2012
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50304257((6S,9S,12S,15S,20aS)-9-((1H-indol-3-yl)methyl)-12-...)
Affinity DataEC50:  75.7nMAssay Description:Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2012
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50304258((6S,9S,12S,15S,20aS)-9,15-bis((1H-indol-3-yl)methy...)
Affinity DataEC50:  20.6nMAssay Description:Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2012
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50304259((6S,9S,12S,15S,20aS)-9,15-bis((1H-indol-3-yl)methy...)
Affinity DataEC50:  16.7nMAssay Description:Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2012
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50413014(CHEMBL497171)
Affinity DataKd:  100nMAssay Description:Antagonist activity at human urotensin 2 receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50413016(CHEMBL496516)
Affinity DataKd:  158nMAssay Description:Antagonist activity at human urotensin 2 receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50413017(CHEMBL500880)
Affinity DataKd:  19.9nMAssay Description:Antagonist activity at human urotensin 2 receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50413018(CHEMBL497561)
Affinity DataKd:  126nMAssay Description:Antagonist activity at human urotensin 2 receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50413020(CHEMBL523566)
Affinity DataKd:  100nMAssay Description:Antagonist activity at human urotensin 2 receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50412075(CHEMBL404177)
Affinity DataKd:  10nMAssay Description:Antagonist activity at human urotensin 2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2012
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50413782(CHEMBL1627325)
Affinity DataEC50:  3.5nMAssay Description:Antagonist activity at human recombinant urotensin 2 receptor expressed in CHO cells assessed as inhibition of urotensin 2-induced intracellular calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50413784(UROTENSIN-II)
Affinity DataEC50:  4.10nMAssay Description:Antagonist activity at human recombinant urotensin 2 receptor expressed in CHO cells assessed as inhibition of urotensin 2-induced intracellular calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50269950(CHEMBL4100932)
Affinity DataEC50:  117nMAssay Description:Allosteric modulation of human urotensin-2 receptor expressed in HEK293 cells assessed as change in URP-induced G12 activation by measuring URP pEC50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50269955(CHEMBL4066696)
Affinity DataEC50:  1.10E+3nMAssay Description:Allosteric modulation of human urotensin-2 receptor expressed in HEK293 cells assessed as change in URP-induced G12 activation by measuring URP pEC50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50269960(CHEMBL4076150)
Affinity DataEC50:  1.95E+3nMAssay Description:Allosteric modulation of human urotensin-2 receptor expressed in HEK293 cells assessed as change in URP-induced G12 activation by measuring URP pEC50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50269946(CHEMBL4071437)
Affinity DataEC50:  8.5nMAssay Description:Allosteric modulation of human urotensin-2 receptor expressed in HEK293 cells assessed as change in human urotensin-2-induced Gq activation by measur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50269950(CHEMBL4100932)
Affinity DataEC50:  14nMAssay Description:Allosteric modulation of human urotensin-2 receptor expressed in HEK293 cells assessed as change in human urotensin-2-induced Gq activation by measur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMed
TargetUrotensin-2 receptor(Human)
Aventis Pharma Germany

Curated by ChEMBL
LigandPNGBDBM50269955(CHEMBL4066696)
Affinity DataEC50:  11nMAssay Description:Allosteric modulation of human urotensin-2 receptor expressed in HEK293 cells assessed as change in human urotensin-2-induced Gq activation by measur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMed
Displayed 1 to 50 (of 752 total ) | Next | Last >>
Jump to: